Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 22

1.

Bioactivation of the epidermal growth factor receptor inhibitor gefitinib: implications for pulmonary and hepatic toxicities.

Li X, Kamenecka TM, Cameron MD.

Chem Res Toxicol. 2009 Oct;22(10):1736-42. doi: 10.1021/tx900256y.

PMID:
19803472
2.

Inhibitors of VIM-2 by screening pharmacologically active and click-chemistry compound libraries.

Minond D, Saldanha SA, Subramaniam P, Spaargaren M, Spicer T, Fotsing JR, Weide T, Fokin VV, Sharpless KB, Galleni M, Bebrone C, Lassaux P, Hodder P.

Bioorg Med Chem. 2009 Jul 15;17(14):5027-37. doi: 10.1016/j.bmc.2009.05.070. Epub 2009 Jun 22.

3.

Characterization of dasatinib and its structural analogs as CYP3A4 mechanism-based inactivators and the proposed bioactivation pathways.

Li X, He Y, Ruiz CH, Koenig M, Cameron MD, Vojkovsky T.

Drug Metab Dispos. 2009 Jun;37(6):1242-50. doi: 10.1124/dmd.108.025932. Epub 2009 Mar 12. Erratum in: Drug Metab Dispos. 2009 Oct;37(10):2118. Vojkovsky, Tomas [added].

4.

Synthesis, antimicrobial and cytotoxic activities of some 5-arylidene-4-thioxo-thiazolidine-2-ones.

Gouveia FL, de Oliveira RM, de Oliveira TB, da Silva IM, do Nascimento SC, de Sena KX, de Albuquerque JF.

Eur J Med Chem. 2009 May;44(5):2038-43. doi: 10.1016/j.ejmech.2008.10.006. Epub 2008 Oct 17.

PMID:
19027993
5.

Drug delivery approaches to overcome bacterial resistance to beta-lactam antibiotics.

Abeylath SC, Turos E.

Expert Opin Drug Deliv. 2008 Sep;5(9):931-49. doi: 10.1517/17425247.5.9.931 . Review.

PMID:
18754746
6.

Metallo-beta-lactamases of Pseudomonas aeruginosa--a novel mechanism resistance to beta-lactam antibiotics.

Sacha P, Wieczorek P, Hauschild T, Zórawski M, Olszańska D, Tryniszewska E.

Folia Histochem Cytobiol. 2008;46(2):137-42. doi: 10.2478/v10042-008-0020-9. Review.

8.

An update on newer beta-lactamases.

Gupta V.

Indian J Med Res. 2007 Nov;126(5):417-27. Review.

PMID:
18160745
9.

Anticancer thiopyrano[2,3-d][1,3]thiazol-2-ones with norbornane moiety. Synthesis, cytotoxicity, physico-chemical properties, and computational studies.

Lesyk R, Zimenkovsky B, Atamanyuk D, Jensen F, Kieć-Kononowicz K, Gzella A.

Bioorg Med Chem. 2006 Aug 1;14(15):5230-40. Epub 2006 May 2.

PMID:
16632367
10.

Imipenem-resistant Pseudomonas aeruginosa producing IMP-1 metallo-beta-lactamases and lacking the outer-membrane protein OprD.

Wang CX, Mi ZH.

J Med Microbiol. 2006 Mar;55(Pt 3):353-4. No abstract available.

PMID:
16476803
11.

Extended-spectrum beta-lactamases: a clinical update.

Paterson DL, Bonomo RA.

Clin Microbiol Rev. 2005 Oct;18(4):657-86. Review.

12.

Miniaturization of absorbance assays using the fluorescent properties of white microplates.

Zuck P, O'Donnell GT, Cassaday J, Chase P, Hodder P, Strulovici B, Ferrer M.

Anal Biochem. 2005 Jul 15;342(2):254-9.

PMID:
15949786
13.

Metallo-beta-lactamases: the quiet before the storm?

Walsh TR, Toleman MA, Poirel L, Nordmann P.

Clin Microbiol Rev. 2005 Apr;18(2):306-25. Review.

14.

Comparative study of the inhibition of metallo-beta-lactamases (IMP-1 and VIM-2) by thiol compounds that contain a hydrophobic group.

Jin W, Arakawa Y, Yasuzawa H, Taki T, Hashiguchi R, Mitsutani K, Shoga A, Yamaguchi Y, Kurosaki H, Shibata N, Ohta M, Goto M.

Biol Pharm Bull. 2004 Jun;27(6):851-6.

15.

Bacterial wall as target for attack: past, present, and future research.

Koch AL.

Clin Microbiol Rev. 2003 Oct;16(4):673-87. Review.

16.

Comparison of methods of interpretation of checkerboard synergy testing.

Bonapace CR, Bosso JA, Friedrich LV, White RL.

Diagn Microbiol Infect Dis. 2002 Dec;44(4):363-6.

PMID:
12543542
17.
18.

Metallo-beta-lactamase: structure and mechanism.

Wang Z, Fast W, Valentine AM, Benkovic SJ.

Curr Opin Chem Biol. 1999 Oct;3(5):614-22. Review.

PMID:
10508665
19.

Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate.

Lauretti L, Riccio ML, Mazzariol A, Cornaglia G, Amicosante G, Fontana R, Rossolini GM.

Antimicrob Agents Chemother. 1999 Jul;43(7):1584-90.

20.

Supplemental Content

Support Center